Literature DB >> 9652571

Monitoring compliance with antituberculous treatment by detection of isoniazid in urine.

J Elizaga, J S Friedland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9652571     DOI： 10.1016/S0140-6736(05)63457-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  The reliability and practicality of the Arkansas method assay of isoniazid adherence.

Authors:  Katharine E Schmitz; Melbourne F Hovell; Charlene A Wong; Norma J Kelley; Donata Nilsen; Elaine J Blumberg; Linda L Hill; Carol L Sipan; Bo Kolody; Dale A Chatfield
Journal:  Clin Nurs Res       Date:  2010-05       Impact factor: 2.075

2.  Point-of-care Arkansas method for measuring adherence to treatment with isoniazid.

Authors:  Renata L Guerra; Marcus B Conde; Anne Efron; Carla Loredo; Gisele Bastos; Richard E Chaisson; Jonathan E Golub
Journal:  Respir Med       Date:  2010-03-03       Impact factor: 3.415

3.  Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.

Authors:  Melbourne F Hovell; Carol L Sipan; Elaine J Blumberg; C Richard Hofstetter; Donald Slymen; Lawrence Friedman; Kathleen Moser; Norma J Kelley; Alicia Y Vera
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

4.  Adherence to self-administered tuberculosis treatment in a high HIV-prevalence setting: a cross-sectional survey in Homa Bay, Kenya.

Authors:  Fabienne Nackers; Helena Huerga; Emmanuelle Espié; Apollo Odongo Aloo; Mathieu Bastard; Jean-François Etard; Joseph Sitienei; Francis Varaine; Jeremiah Chakaya; Maryline Bonnet
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

5.  Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.

Authors:  Tom A Szakacs; Douglas Wilson; D William Cameron; Michael Clark; Paul Kocheleff; F James Muller; Anne E McCarthy
Journal:  BMC Infect Dis       Date:  2006-06-13       Impact factor: 3.090

6.  Adherence, tolerability, and outcome after 36 months of isoniazid-preventive therapy in 2 rural clinics of Swaziland: A prospective observational feasibility study.

Authors:  Yolanda Mueller; Qhubekani Mpala; Bernhard Kerschberger; Barbara Rusch; Gugu Mchunu; Sikhathele Mazibuko; Maryline Bonnet
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

7.  Lessons learned from two interventions designed to increase adherence to LTBI treatment in Latino youth.

Authors:  Melbourne F Hovell; Katharine E Schmitz; Elaine J Blumberg; Linda Hill; Carol Sipan; Lawrence Friedman
Journal:  Contemp Clin Trials Commun       Date:  2018-08-16

8.  Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities.

Authors:  Ramnath Subbaraman; Laura de Mondesert; Angella Musiimenta; Madhukar Pai; Kenneth H Mayer; Beena E Thomas; Jessica Haberer
Journal:  BMJ Glob Health       Date:  2018-10-11

9.  Evaluation of the Accuracy of 99DOTS, a Novel Cellphone-based Strategy for Monitoring Adherence to Tuberculosis Medications: Comparison of DigitalAdherence Data With Urine Isoniazid Testing.

Authors:  Beena E Thomas; J Vignesh Kumar; M Chiranjeevi; Daksha Shah; Amit Khandewale; Kannan Thiruvengadam; Jessica E Haberer; Kenneth H Mayer; Ramnath Subbaraman
Journal:  Clin Infect Dis       Date:  2020-12-03       Impact factor: 9.079

10.  Understanding Nonadherence to Tuberculosis Medications in India Using Urine Drug Metabolite Testing: A Cohort Study.

Authors:  Ramnath Subbaraman; Beena E Thomas; J Vignesh Kumar; Kannan Thiruvengadam; Amit Khandewale; S Kokila; Maya Lubeck-Schricker; M Ranjith Kumar; Gunjan Rahul Gaurkhede; Apurva Shashikant Walgude; J Hephzibah Mercy; Jagannath Dattatraya Kumbhar; Misha Eliasziw; Kenneth H Mayer; Jessica E Haberer
Journal:  Open Forum Infect Dis       Date:  2021-05-05       Impact factor: 3.835
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.